One of the first preclinical studies to discriminate between neutrophil states in cancer described N1/anti-tumorigenic and N2/pro-tumorigenic neutrophils within tumors, whereby transition to N2 was regulated by TGF-β (Fridlender et al., 2009). This evidence concerns the gene TGFB1 and cancer.